Articles from:
1999 Regional Initiatives Articles
-
While financial markets may believe there are too many biotechnology companies
in the world, research suggests that the opposite is true.
-
Government initiatives, growth of small-cap markets, and a change in investor
attitudes has promoted an increase in European venture funding.
-
Cultural factors suggest that European venture capitalists will follow
a different model than their US counterparts in selecting companies to fund.
-
A virtual organization coordinating the resources of 170 companies and
research institutes is providing a dramatic push forward for German biotechnology.
-
There are many ways to access German money, but the decision must be based
on sound strategy rather than a dire need.
-
Yes, if it is to have the resources needed to develop products of interest
to large pharmaceutical partners.
-
Scandinavia's Medicon Valley is experiencing a spurt of funding, prompted
by a combination of government and private capital.
-
A growing biotechnology industry depends on venture capital for more than
money.
-
Universities continue to foster new company formation in Europe's limited
venture capital system.
Main navigation
NPG Journals
by Subject Area
Chemistry
Clinical Practice & Research
Earth & Environment
Life sciences
Physical sciences
Top
